A collection of news, blogs and updates to keep you aligned with the latest Shweed developments.
This week marks the 4th anniversary of medical cannabis legalisation in the UK – the result of years of passionate campaigning and lobbying by patients and activists. We take a look at the situation four years on.
the scientific community has been aware of terpenes for a long time; they are present in many plants, including cannabis, and are known to have a number of impressive therapeutic properties.
Outdated hemp cultivation regulations and laws mean that cultivators, manufacturers and brand owners are continuing to lose out on a huge CBD market that appears to be going nowhere.
German lawmakers have been busy touring American and Canadian cannabis dispensaries while facing the reality of policy hurdles in preparation for legalisation.
When it comes to cannabis, Canada has long been considered one of the world’s most progressive nations. We take a look at Canada’s cannabis legacy.
The first full week of September 2022 has been one of celebration, shock, and mourning. Not only has the country welcomed a new Prime Minister, but it has also saluted the passing of the longest-reigning monarch in Britain’s history. Just two days after swearing in...
Continuing with our series of cannabis market analysis, we are taking a closer look at the ever-progressing cannabis market in the US.
Both medical and recreational ‘cannabis’ sectors are beginning to see the adoption of synthetic cannabinoids – but what are they?
In honour of National CBD Day, we here at Shweed are going to be taking a closer look at the medicinal properties of CBD, the history of its use and the view for the future.
We aim to explain how GMP regulations are applied to medical cannabis products and why they are important.